Skip to main content

Find Clinical Trials

Home
Conditions
Blasts 20 Percent or More of Bone Marrow Nucleated Cells

Clinical trial condition

Blasts 20 Percent or More of Bone Marrow Nucleated Cells

Explore clinical trials studying Blasts 20 Percent or More of Bone Marrow Nucleated Cells. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Blasts 20 Percent or More of Bone Marrow Nucleated Cells trial results

Recruiting

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT04047641

Conditions: Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, Hematologic Diseases, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details